Skip to main content

Table 3 Demographic data and OA history of the FAS population (N = 81)

From: Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial

 

IAHA

N = 40

Saline solution

N = 41

Total

N = 81

P value

Test

Age (years)

66.9 ± 10.4

63.0 ± 8.9

65.0 ± 9.8

0.0752

Student

Sex

     

 - Women

 - Men

62.5%

37.5%

75.6%

24.4%

69.1%

30.9%

0.2016

Chi-square test

BMI (kg/m2)

29.0 ± 7.4

30.8 ± 7.2

29.9 ± 7.3

0.2465

Student

Disease duration (year)

7.6 ± 8.0

5.9 ± 5.3

6.7 ± 6.8

0.2639

Student

Evaluated knee

     

 - Right

45.0%

48.8%

46.9%

  

 - Left

55.0%

51.2%

53.1%

0.7332

Chi-square test

Radiological score (K&L)

     

 - Score II

52.5%

58.5%

55.6%

  

 - Score III

47.5%

41.5%

44.4%

0.5846

Chi-square test

Night pain

52.5%

56.1%

54.3%

0.7452

Chi-square test

Effusion

20.0%

14.6%

17.3%

0.5231

Chi-square test

OA treatment for the past 3 months

     

 - Acetomiphen

27.5%

41.5%

32.1%

0.2155

Chi-square test

 - NSAIDS

15.0%

12.2%

13.6%

0.7126

Chi-square test

 - slow acting anti OA drugs

7.5%

9.8%

8.6%

0.7179

Chi-square test